Moors & Cabot, Inc. Amyris, Inc. Transaction History

Moors & Cabot, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.58 - $1.3 $3,334 - $7,475	-5,750 Reduced 5.23%	104,250 $107,000
Q1 2023 May 04, 2023	BUY	$1.09 - $1.82 $8,175 - $13,650	7,500 Added 7.32%	110,000 $149,000
Q4 2022 Feb 09, 2023	BUY	$1.52 - $3.39 $76,380 - $170,347	50,250 Added 96.17%	102,500 $156,000
Q4 2022 Feb 06, 2023	SELL	$1.52 - $3.39 $102,220 - $227,977	-67,250 Reduced 56.28%	52,250 $79,000
Q3 2022 Nov 07, 2022	BUY	$1.7 - $4.05 $64,175 - $152,887	37,750 Added 46.18%	119,500 $349,000
Q2 2022 Aug 08, 2022	BUY	$1.6 - $5.07 $31,200 - $98,865	19,500 Added 31.33%	81,750 $151,000
Q1 2022 May 13, 2022	BUY	$3.92 - $5.86 $39,200 - $58,600	10,000 Added 19.14%	62,250 $271,000
Q4 2021 Feb 14, 2022	BUY	$5.0 - $14.85 $179,250 - $532,372	35,850 Added 218.6%	52,250 $283,000
Q3 2021 Nov 05, 2021	BUY	$12.13 - $16.99 $198,932 - $278,636	16,400 New	16,400 $388,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.